Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink

OBJECTIVES: To compare population-based incidence rates of new-onset depression or self-harm in patients initiating incretin-based therapies with that of sulfonylureas (SU) and other glucose-lowering agents. DESIGN: Population-based cohort study. SETTING: Patients attending primary care practices re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamble, John-Michael, Chibrikov, Eugene, Midodzi, William K, Twells, Laurie K, Majumdar, Sumit R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194463/
https://www.ncbi.nlm.nih.gov/pubmed/30297350
http://dx.doi.org/10.1136/bmjopen-2018-023830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194463/
https://www.ncbi.nlm.nih.gov/pubmed/30297350
http://dx.doi.org/10.1136/bmjopen-2018-023830

Ejemplares similares